ConocoPhillips Plans Lower 2027 Capex While Targeting Production Growth

What happened

ConocoPhillips announced plans for modestly lower 2027 capital spending while still targeting production growth, relying on low-cost resources and efficiency gains. This follows the integration of Marathon Oil and ongoing cost-reduction efforts aimed at improving free cash flow. The market is questioning whether such growth is achievable with lower capex, given previous capital intensity and rising per-BOE costs. While the company has a track record of maintaining production with disciplined spending, the proof of efficiency gains remains pending. Overall, this news is consistent with the existing WAIT thesis, as the stock trades near fair value and execution risks are not yet resolved.

Implication

Over the next 6-12 months, watch for evidence that 2027 capex guidance is indeed lower and that production targets are met without cost overruns. If oil prices remain weak, the company may struggle to generate sufficient free cash flow to sustain buybacks and dividends. Key metrics to monitor are per-BOE production costs and DD&A trends; if these do not decline, the efficiency narrative is weakened. The news does not alter the fundamental valuation, which is near fair value at current prices; a more attractive entry would be around $85. Any upside beyond $115 requires clear demonstration of cost reductions and higher oil prices, which is not yet evident.

Thesis delta

The announcement of lower 2027 capex with production growth is generally positive but does not change the core thesis; the company remains in a 'show me' phase. The DeepValue report already assumed flat-to-2% production growth at approximately $12 billion capex, so this guidance is within expectations. However, if ConocoPhillips can achieve growth with meaningfully lower capex, it would increase confidence in the efficiency program and could support a higher rating in the future.